Skip to main navigation Skip to search Skip to main content

VKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement

Translated title of the contribution: VKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement
  • T. Schalekamp
  • , B.P. Brassé
  • , J.F.M. Roijers
  • , E. van Meegen
  • , F.J.M van der Meer
  • , E.M. van Wijk
  • , A.C.G. Egberts
  • , A. de Boer

Research output: Contribution to journalArticleAcademicpeer-review

Translated title of the contributionVKORC1 and CYP2C9 Genotypes and Phenprocoumon Anticoagulation Status: Interaction Between both Genotypes Affects Dose Requirement
Original languageUndefined/Unknown
Pages (from-to)185-193
Number of pages9
JournalClinical Pharmacology & Therapeutics
Volume81
Issue number2
Publication statusPublished - 2007

Keywords

  • Econometric and Statistical Methods: General
  • Epidemiology
  • Farmacie(FARM)
  • Geneeskunde(GENK)
  • Biomedische technologie en medicijnen
  • Ziekenhuisstructuur en organisatie van de gezondheidszorg
  • Public Health
  • Pharmacology

Cite this